CQP(SZ:000950)2023-01-11 23:04Group 1: Strategic Planning - The company's "14th Five-Year" strategic plan aims for revenue exceeding 100 billion by 2025, with a focus on dual internal and external growth [2] - The plan includes a nationwide commercial network covering over 300 regions, emphasizing integrated retail and wholesale, product diversification, and digital business [2] - Key capabilities targeted include marketing solutions, supply chain solutions, IT solutions, and clinical support solutions [2] Group 2: Business Segments - The medical device segment is a crucial part of the business, with goals to establish a nationwide network and achieve scale effects during the "14th Five-Year" period [3] - The company aims to transition to a service-driven and technology-driven medical device service provider, enhancing its competitive position in the market [3] - The company plans to leverage regional advantages in areas like Guizhou and Sichuan to gain national influence in specific segments such as orthopedics and maternal and child health [3] Group 3: Logistics and Supply Chain - The company has a sophisticated logistics distribution system focused on pharmaceutical supply chain services, with multiple distribution centers across various provinces [3][4] - The logistics company manages over 90,000 square meters of central warehouse space in Chongqing, adhering to GSP and international storage standards [4] - The central distribution center located in the Chongqing Free Trade Zone offers advantages such as local customs clearance [4] Group 4: Investor Relations Activity - The investor relations activity on January 11, 2023, involved discussions on the company's strategic planning and business performance [2][5] - No undisclosed significant information was leaked during the activity, ensuring compliance with disclosure regulations [5]